Oil Giant Shell Appeals Landmark Climate Ruling: Report

Dutch court hears Shell's appeal against climate ruling to drastically reduce emissions by 45% by 2030. Shell faces pressure to invest in renewables.

A Dutch court will hear Shell plc’s (NYSE:SHEL) appeal against a landmark climate ruling that drastically deepened the oil giant’s planned greenhouse gas emission cuts.

In 2021, the district court in The Hague ordered the oil and gas giant to lower its carbon emissions by 45% by 2030 vs. 2019 levels.

The order came amid rising pressure on energy companies from investors, activists, and governments to boost investment in renewables and move away from fossil fuels, said Reuters.

RelatedShell Streamlines Renewables Portfolio with SouthCoast Wind Sale

The company had said in a statement, “We agree that the world needs urgent climate action, but we have a different view in how that goal should be achieved”.

“By focusing on one company, and only on the supply of energy rather than the demand for it, we believe the ruling is ineffective and even counterproductive in addressing climate change.”

Last month, Shell stated that they have achieved more than 60% of the target to halve emissions from its operations (Scope 1 and 2) by 2030 vs. 2016 on a net basis.

The company also set a new ambition to reduce customer emissions from the use of its oil products by 15%-20% by 2030 compared with 2021 and against its previous target of 20%.

Acknowledging uncertainty in the pace of change in the energy transition, the company has also chosen to retire its 2035 target of a 45% reduction in net carbon intensity. 

The company reiterated the investment of $10 billion-$15 billion between 2023-2025 in low-carbon energy solutions.

Price Action: SHEL shares are up 1.19% at $68.74 premarket on the last check Tuesday.

Photo via Wikimedia Commons

Total
0
Shares
Related Posts
Read More

Fear & Greed Index Moves To ‘Neutral’ Zone Ahead Of US NFP Report

The CNN Money Fear and Greed index moved to the "Neutral" zone a day after the Federal Reserve announced another 0.75 percentage point rate hike on Wednesday. U.S. stocks recorded losses for the fourth session in a row ahead of the much-awaited data on nonfarm payrolls. For the week, all the major indices are on course to record losses.

CAH

Read More

On May 14, 2024, Paragon Therapeutics Announced A License Agreement Granting Spyre Therapeutics An Exclusive License To Certain Antibodies And Products Targeting α4SS7 Integrin And Tl1A, Paragon Will Up To $22M In Milestone Payments-8K

Paragon will provide the Company with an exclusive license to its patents covering the related antibody, the method of use and its method of manufacture. Paragon will not conduct any new campaigns that generate

SYRE